Testosterone-metabolizing capacity and characteristics of adrenal microsomes in human fetus in Vitro

Journal of Pediatric Endocrinology and Metabolism

Volumn 23, Issue 1-2, 2010, Pages 143-152

  Wang, Hui ^a   Xu, Dan ^a   Peng, R X ^a   Yue, Jiang ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Adrenal; Cytochrome p450; Human fetus; Liver; Testosterone metabolism

Indexed keywords

16ALPHA HYDROXYESTRONE; ANDROSTENEDIONE; CYTOCHROME P450 2C; CYTOCHROME P450 3A; DROSTANOLONE; ERYTHROMYCIN; HYDROXYCORTICOSTEROID; OMEPRAZOLE; OXENDOLONE; SULFAPHENAZOLE; TESTOSTERONE; TESTOSTERONE DERIVATIVE;

ADRENAL GLAND; ADULT; ARTICLE; CONTROLLED STUDY; FETUS; FETUS (ANATOMY); FETUS LIVER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE DETERMINATION; HORMONE METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METABOLISM; MICROSOME; PROTEIN ISOLATION; PROTEIN VARIANT; SPECTROSCOPY; TESTOSTERONE METABOLISM;

EID: 77950786733     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2010.23.1-2.143     Document Type: Article

References (34)

1. Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction 2004; 127: 515-526.
2. 2. Fowden AL, Giussani DA, Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 2005; 81: 723-734. (Pubitemid 41253517)
3. 3. Reynolds RM, Walker BR, Syddall HE, Andrew R, Wood PJ, Whorwood CB, Phillips DI. Altered control of Cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab 2001; 86: 245-250. (Pubitemid 32109803)
4. 4. Fernandez-Twinn DS, Ozanne SE, Ekizoglou S, Doherty C, James L, Gusterson B, Hales CN. The maternal endocrine environment in the low-protein model of intra-uterine growth restriction. Br J Nutr 2003;90:815-822. (Pubitemid 37270765)
5. Seckl JR. Glucocorticoids, feto-placental 11 betahydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 1997; 62: 89-94.
6. New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, Lin-Su K, Putnam AS, Wei JQ, Wilson RC. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001; 86: 5651-5657.
7. 7. Wolf CJ, Hotchkiss A, Ostby JS, LeBlanc GA, Gray LE Jr. Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicol Sci 2002; 65: 71-76. (Pubitemid 34092692)
8. 8. Birch RA, Padmanabhan V, Foster DL, Robinson JE. Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology 2003; 144: 1426-1434. (Pubitemid 36428485)
9. 9. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, Brown MB, Foster DL, Padmanabhan V. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004; 145: 790-798. (Pubitemid 38183822)
10. Manikkam M, Steckler TL, Welch KB, Inskeep EK, Padmanabhan V. Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology 2006; 147: 1997-2007.
11. 11. Maenpaa J, Pelkonen O, Cresteil T, Rane A. The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol 1993; 44: 61-67. (Pubitemid 23070573)
12. Black VH, Wittig JC, Cheung P. Intraadrenal steroid metabolism in the guinea pig: guinea pig adrenal microsomes metabolize androstenedione in a manner distinct from liver microsomes. Endocr Res 1995; 21: 315-328.
13. 13. Borlak J, Schulte I, Thum T. Androgen metabolism in thymus of fetal and adult rats. Drug Metab Dispos 2004; 32: 675-679. (Pubitemid 38668161)
14. 14. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997; 18: 378-403. (Pubitemid 27246882)
15. Coulter CL. Fetal adrenal development: insight gained from adrenal tumors. Trends Endocrinol Metab 2005; 16: 235-242.
16. Wang H, Peng RX, Yu JP, Zhang YH. Expression and inducibility in vitro of cytochrome P-450 1, 2 and 3 in human fetal adrenals. Asia Pac J Pharmacol 2000; 14: 33-38.
17. 17. Wang H, Peng RX, Zhang YH, Chen JH, Li QX, Kong R. Demethylation capacity of human fetal adrenal mitochrondrial P-450 in vitro. Acta Pharmacol Sinic 1999; 20: 358-362. (Pubitemid 29193601)
18. Sanwald P, Blankson EA, Dulery BD, Schoun J, Huebert ND, Dow J. Isocratic high-performance liquid chromatographic method for the separation of testosterone metabolites. J Chromatography B 1995; 672: 207-215.
19. 19. Melet A, Assrir N, Jean P, Pilar Lopez-Garcia M, Marques-Soares C, Jaouen M, Dansette PM, Sari MA, Mansuy D. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid. Arch Biochem Biophys 2003; 409: 80-91. (Pubitemid 36042904)
20. 20. Yin OQ, Tomlinson B, Chow AH, Waye MM, Chow MS. Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability. J Clin Pharmacol 2004; 44: 582-589. (Pubitemid 38668020)
21. Wang RW, Newton DJ, Scheri TD, Lu AY. Human cytochrome P450 3A4-catalyzed testosterone 6 betahydroxylation and erythromycin N-demethylation. Competition during catalysis. Drug Metab Dispos 1997; 25: 502-507.
22. Lemahieu WP, Maes BD, Ghoos Y, Rutgeerts P, Verbeke K, Vanrenterghem Y. Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test. Am J Physiol Gastrointest Liver Physiol 2003; 285: 470-482.
23. 23. Whalley PM, Bakes D, Grime K, Weaver RJ. Rapid high-performance liquid chromatographic method for the separation of hydroxylated testosterone metabolites. J Chromatogr B Biomed Sci Appl 2001; 760: 281-288. (Pubitemid 32727251)
24. 24. Usmani KA, Rose RL, Hodgson E. Inhibition and activation of the human liver microsomal and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals. Drug Metab Dispos 2003; 31: 384-391. (Pubitemid 36378515)
25. Waxman DJ. Interactions of hepatic cytochromes P450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem Pharmacol 1988; 37: 71-84.
26. 26. Yamazaki H, Shimada T. Progesterone and testosterone hydroxylation by cytochromes P4502C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 1997; 346: 161-169. (Pubitemid 27415307)
27. 27. Schuetz JD, Beach DL, Guzelian PS. Selective expression of cytochrome P450CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 1994; 4: 11-20. (Pubitemid 24106119)
28. 28. Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y. Purification and properties of cytochrome P-450 from homogenates of human fetal liver. Arch Biochem Biophys 1985; 241:275-280. (Pubitemid 15012034)
29. 29. Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y. Significance of cytochrome P-450 (P450HFLa) of human fetal livers in the steroid and drug oxidation. Biochem Pharmacol 1987; 36: 453-456. (Pubitemid 17024166)
30. Shigeru O, Hiromitsu N, Kazuki A, Yasusi K, Itsuko I, Masakiyo H, Mitskazu K. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS7 cells. Biochim Biophys Acta 1998; 1380: 297-304.
31. 31. Ohmori S, Fujiki N, Nakasa H, Nakamura H, Ishii I, Itahashi K, Kitada M. Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus. Res Commun Mol Pathol Pharmacol 1998; 100: 15-28. (Pubitemid 28283635)
32. Wang H, Huang M, Peng RX, Le J. Influences of 3methylcholanthrene, phenobarbital and dexamethasone on xenobiotic metaboljzing-related cytochrome P450 enzymes and steroidogenesis in human fetal adrenal cortical cells. Acta Pharmacol Sin 2006; 27: 1093-1096.
33. 33. Steckler T, Wang J, Bartol FF, Roy SK, Padmanabhan V. Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology 2005; 146: 3185-3193. (Pubitemid 41007051)
34. 34. Sharma TP, Herkimer C, West C, Ye W, Birch R, Robinson JE, Foster DL, Padmanabhan V. Fetal programming: prenatal androgen disrupts positive feedback actions of estradiol but does not affect timing of puberty in female sheep. Biol Reprod 2002; 66: 924-933. (Pubitemid 34263111)